This study demonstrates that increased glycolysis in PDAC tumors results in a low-glucose, high-lactate tumor microenvironment (TME), which suppresses immune cell function, particularly dendritic cells (DCs) and CD8 + T cells. The gene discussed is CD8A; the disease is neoplasm.